{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T10:55:19Z","timestamp":1761216919748},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3780,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1111\/j.1523-1755.2005.00425.x","type":"journal-article","created":{"date-parts":[[2005,7,12]],"date-time":"2005-07-12T18:03:59Z","timestamp":1121191439000},"page":"474-486","source":"Crossref","is-referenced-by-count":6,"title":["The inhibition of human mesangial cell proliferation by S-trans, trans-farnesylthiosalicylic acid"],"prefix":"10.1016","volume":"68","author":[{"given":"Arif","family":"Khwaja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire C.","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazhar","family":"Noor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoel","family":"Kloog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce M.","family":"Hendry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0272-6386(12)80971-1","article-title":"Mechanisms of progressive renal disease in glomerulonephritis","volume":"23","author":"Couser","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0015","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1046\/j.1523-1755.1999.00710.x","article-title":"Regulation of mesangial cell proliferation","volume":"56","author":"Schocklmann","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0020","first-page":"297","article-title":"Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1.1 model)","volume":"12","author":"Jefferson","year":"1999","journal-title":"J Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0025","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/ki.1991.235","article-title":"Increased synthesis of extracellular matrix in mesangial proliferative nephritis","volume":"40","author":"Floege","year":"1991","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0030","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1084\/jem.175.5.1413","article-title":"Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor","volume":"175","author":"Johnson","year":"1992","journal-title":"J Exp Med"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0035","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1172\/JCI116918","article-title":"Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats","volume":"92","author":"Floege","year":"1993","journal-title":"J Clin Invest"},{"issue":"Suppl","key":"10.1111\/j.1523-1755.2005.00425.x_bb0040","first-page":"S2","article-title":"Cytokines, growth factors and renal injury: Where do we go now?","volume":"63","author":"Johnson","year":"1997","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0045","doi-asserted-by":"crossref","first-page":"R258","DOI":"10.1016\/S0960-9822(06)00116-3","article-title":"Cell cycle: Routine role for Ras","volume":"7","author":"Downward","year":"1997","journal-title":"Curr Biol"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc969","article-title":"Targeting RAS signalling pathways in cancer therapy","volume":"3","author":"Downward","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1152\/physrev.2001.81.1.153","article-title":"Small GTP-binding proteins","volume":"81","author":"Takai","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/08830189809084488","article-title":"Signal transduction through cytokine receptors","volume":"17","author":"Hibi","year":"1998","journal-title":"Int Rev Immunol"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0065","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/sj.onc.1202186","article-title":"Cell growth control by G protein-coupled receptors: From signal transduction to signal integration","volume":"17","author":"Gutkind","year":"1998","journal-title":"Oncogene"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0070","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1388-1981(00)00009-3","article-title":"Recent advances in the study of prenylated proteins","volume":"1484","author":"Sinensky","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-291X(03)00323-1","article-title":"Protein prenylation: A pivotal posttranslational process","volume":"303","author":"Roskoski","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0092-8674(00)80607-8","article-title":"Endomembrane trafficking of ras: The CAAX motif targets proteins to the ER and Golgi [see comments]","volume":"98","author":"Choy","year":"1999","journal-title":"Cell"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0092-8674(90)90294-O","article-title":"A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane","volume":"63","author":"Hancock","year":"1990","journal-title":"Cell"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0090","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1021\/jm00008a004","article-title":"Farnesyl derivatives of rigid carboxylic acids\u2014Inhibitors of ras-dependent cell growth","volume":"38","author":"Marciano","year":"1995","journal-title":"J Med Chem"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0095","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1021\/bi972032d","article-title":"Dislodgment and accelerated degradation of Ras","volume":"37","author":"Haklai","year":"1998","journal-title":"Biochemistry"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0100","doi-asserted-by":"crossref","first-page":"22263","DOI":"10.1074\/jbc.270.38.22263","article-title":"Selective inhibition of Ras-dependent cell growth by farnesylthiosalisylic acid","volume":"270","author":"Marom","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0105","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0167-4889(99)00144-5","article-title":"Targeting of K-Ras 4B by S-trans,trans-farnesyl thiosalicylic acid","volume":"1452","author":"Elad","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0110","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/(SICI)1097-0215(19990315)80:6<911::AID-IJC18>3.0.CO;2-4","article-title":"Growth inhibition of ras-dependent tumors in nude mice by a potent ras-dislodging antagonist","volume":"80","author":"Egozi","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0115","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0168-8278(99)80318-3","article-title":"The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally induced liver cirrhosis in rats","volume":"31","author":"Reif","year":"1999","journal-title":"J Hepatol"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0120","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1046\/j.1365-2249.2001.01674.x","article-title":"Treatment of MRL\/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS)","volume":"126","author":"Katzav","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0125","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/01.ASN.0000057543.55318.8B","article-title":"Ras antagonist farnesylthiosalicylic acid (FTS) reduces glomerular cellular proliferation and macrophage number in rat thy-1 nephritis","volume":"14","author":"Clarke","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0130","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1681\/ASN.V1061186","article-title":"Evidence of a role for Ki-Ras in the stimulated proliferation of renal fibroblasts","volume":"10","author":"Sharpe","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0135","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0","article-title":"ERK1\/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion","volume":"186","author":"Jones","year":"2001","journal-title":"J Cell Physiol"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0140","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/ndt\/16.6.1139","article-title":"In vitro evidence for differential involvement of CTGF, TGFbeta, and PDGF-BB in mesangial response to injury","volume":"16","author":"Blom","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0145","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1172\/JCI117348","article-title":"Expression of platelet-derived growth factor receptors in normal and diseased human kidney. An immunohistochemistry and in situ hybridization study","volume":"94","author":"Gesualdo","year":"1994","journal-title":"J Clin Invest"},{"issue":"Suppl","key":"10.1111\/j.1523-1755.2005.00425.x_bb0150","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1046\/j.1523-1755.2000.07509.x","article-title":"The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease","volume":"75","author":"Klahr","year":"2000","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0155","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(99)08347-6","article-title":"Prenylation inhibitors in renal disease","volume":"355","author":"Khwaja","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0160","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc1143","article-title":"The emerging role of lysophosphatidic acid in cancer","volume":"3","author":"Mills","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0165","doi-asserted-by":"crossref","first-page":"7486","DOI":"10.1038\/sj.onc.1204950","article-title":"Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation","volume":"20","author":"Paz","year":"2001","journal-title":"Oncogene"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0170","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1038\/sj.onc.1202602","article-title":"A new functional Ras antagonist inhibits human pancreatic tumor growth in nude mice","volume":"18","author":"Weisz","year":"1999","journal-title":"Oncogene"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0175","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1006\/bbrc.1997.7582","article-title":"The Ras antagonist S-farnesylthiosalicylic acid induces inhibition of MAPK activation","volume":"239","author":"Gana-Weisz","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0180","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","article-title":"PI3K\/Akt signalling pathway and cancer","volume":"30","author":"Fresno Vara","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0190","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1006\/excr.1999.4702","article-title":"Bioactive lysophospholipids and their G protein-coupled receptors","volume":"253","author":"Moolenaar","year":"1999","journal-title":"Exp Cell Res"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0195","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ijc.10213","article-title":"Farnesyl thiosalicylic acid inhibits the growth of melanoma cells through a combination of cytostatic and pro-apoptotic effects","volume":"98","author":"Smalley","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0200","doi-asserted-by":"crossref","first-page":"14019","DOI":"10.1073\/pnas.96.24.14019","article-title":"Novel Ras antagonist blocks human melanoma growth","volume":"96","author":"Jansen","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0205","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.bbrc.2003.08.055","article-title":"STI-571: An anticancer protein-tyrosine kinase inhibitor","volume":"309","author":"Roskoski","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1523-1755.2005.00425.x_bb0210","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1046\/j.1523-1755.2001.0590041324.x","article-title":"PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis","volume":"59","author":"Gilbert","year":"2001","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815508673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815508673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T13:22:44Z","timestamp":1648300964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815508673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0085253815508673"],"URL":"https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00425.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}